Navigating Hormone Therapy Choices After OophorectomyFor women carrying BRCA1 or BRCA2 pathogenic variants, the decision to ...
A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.
The full name of the BRCA1 gene is “breast cancer 1, early onset,” and it codes for a tumor suppressor protein. Tumor suppressor proteins help repair DNA that has become damaged in order to ensure the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results